NAUT FY 2023 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$339M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6M

Operating Income

-$76M

Net Income

-$64M

EPS (Diluted)

$-0.51

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$54M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$306M

Total Liabilities

$40M

Stockholders' Equity

$265M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6M	-$3M	-67.0%
Operating Income	-$76M	-$64M	-19.7%
Net Income	-$64M	-$58M	-9.9%